SANUWAVE Health (SNWV) Stock: Buy, Sell, or Hold?
SNWV - SANUWAVE Health, Inc. Common Stock
$5.26
-0.04 (-0.75%)
âŧ
5d:
+6.05%
30d:
+8.45%
90d:
-13.77%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 06, 2026
13d
Get Alerted When SNWV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SNWV is fairly priced but lacks strong directional signals. At -16.4% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SNWV is fairly priced but lacks strong directional signals. At -16.4% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.70
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$7.89
33.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNWV is currently trading at $5.26, which is considered slightly high relative to its 30-day fair value range of $4.46 to $5.41. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.3) compared to its historical average (24.5). Remarkably, the market is currently pricing in an annual earnings decline of 16.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNWV is in a strong downtrend. Immediate support is located at $4.78, while resistance sits at $5.98.
Market Sentiment: SNWV scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $40.00 (+654.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNWV is in a strong downtrend. Immediate support is located at $4.78, while resistance sits at $5.98.
Market Sentiment: SNWV scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $40.00 (+654.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$4.46 -
$5.41
Company Quality Score
28/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.9%
All Signals
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 654.7% below Wall St target ($40.00)
- WARNING: Composite score 28/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.46 -
$5.41
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.78
Resistance Level
$5.98
Current Trend
Strong Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.32
Wall Street Target
$40.00
(+654.7%)
Revenue Growth (YoY)
-3.1%
Earnings Growth (YoY)
-99.6%
Profit Margin
34.7%
Valuation Discount vs History
-16.4% cheaper
PE vs Historical
14.3 vs 24.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.4%
(market-implied from PE analysis)
1-Year Target
$4.77
(-10%)
2-Year Target
$4.29
(-19%)
3-Year Target
$3.86
(-27%)
3-Yr Target (if PE normalizes)
(PE: 14â25)
$6.61
(+25%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 22.25 | Current EPS (TTM): $0.24
Bull Case
$9.06
(+71%)
Analyst growth 54.2%, PE expands to 24.5
Base Case
$8.23
(+55%)
Market implied 54.2%, PE stable at 22.3
Bear Case
$3.63
(-32%)
Severe decline -20.0%, PE contracts to 18.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.3 to 24.5
Stabilization Target:
$9.06
(+71.0%)
PE Expansion Potential:
+71.0%
Share & Embed Analysis
Last updated: October 23, 2026 1:08 PM ET
Data refreshes hourly during market hours. Next update: 2:08 PM
Data refreshes hourly during market hours. Next update: 2:08 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNWV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 38 SELL |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 70 BUY |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$167 | 37 SELL |
